Westwind Capital Reduces Stock Position in Humana Inc. $HUM

Westwind Capital reduced its position in shares of Humana Inc. (NYSE:HUM) by 4.7% in the third quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 28,266 shares of the insurance provider’s stock after selling 1,391 shares during the quarter. Humana accounts for about 2.6% of Westwind Capital’s investment portfolio, making the stock its 12th biggest holding. Westwind Capital’s holdings in Humana were worth $10,785,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Gradient Investments LLC boosted its stake in Humana by 2.5% during the 3rd quarter. Gradient Investments LLC now owns 13,738 shares of the insurance provider’s stock valued at $5,242,000 after purchasing an additional 330 shares during the last quarter. Valeo Financial Advisors LLC lifted its holdings in shares of Humana by 15.3% during the third quarter. Valeo Financial Advisors LLC now owns 814 shares of the insurance provider’s stock valued at $310,000 after purchasing an additional 108 shares in the last quarter. Vista Investment Partners LLC purchased a new stake in shares of Humana during the third quarter valued at $3,254,000. Lake Hills Wealth Management LLC increased its holdings in Humana by 6.3% in the 3rd quarter. Lake Hills Wealth Management LLC now owns 2,312 shares of the insurance provider’s stock worth $882,000 after buying an additional 138 shares in the last quarter. Finally, Versant Capital Management Inc increased its holdings in Humana by 16.4% in the 3rd quarter. Versant Capital Management Inc now owns 688 shares of the insurance provider’s stock worth $263,000 after buying an additional 97 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Analyst Upgrades and Downgrades

A number of analysts have recently issued reports on the stock. Robert W. Baird set a $390.00 price target on shares of Humana in a report on Thursday, July 30th. Royal Bank Of Canada raised their target price on shares of Humana from $246.00 to $415.00 and gave the stock a “sector perform” rating in a report on Thursday, July 9th. Wells Fargo & Company raised shares of Humana from an “equal weight” rating to an “overweight” rating and lifted their target price for the stock from $227.00 to $502.00 in a research report on Monday, July 13th. TD Cowen lifted their price objective on Humana from $350.00 to $370.00 and gave the stock a “hold” rating in a report on Friday, July 31st. Finally, Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and upped their price objective for the company from $249.00 to $370.00 in a research report on Tuesday, August 4th. Sixteen research analysts have rated the stock with a Buy rating, thirteen have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $422.52.

Humana Stock Performance

NYSE HUM traded down $8.83 on Thursday, hitting $387.68. 2,651,655 shares of the company traded hands, compared to its average volume of 1,649,764. The business’s 50 day moving average price is $387.26 and its 200-day moving average price is $332.87. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The company has a market capitalization of $46.55 billion, a price-to-earnings ratio of 36.68, a P/E/G ratio of 2.49 and a beta of 0.74.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 EPS for the quarter, topping the consensus estimate of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion for the quarter, compared to the consensus estimate of $40.58 billion. During the same quarter last year, the company earned $6.27 earnings per share. The business’s revenue for the quarter was up 26.2% compared to the same quarter last year. Equities analysts expect that Humana Inc. will post 9.01 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, November 27th. Shareholders of record on Friday, October 30th will be given a $0.8850 dividend. This represents a $3.54 dividend on an annualized basis and a dividend yield of 0.9%. The ex-dividend date is Friday, October 30th. Humana’s dividend payout ratio is presently 33.49%.

More Humana News

Here are the key news stories impacting Humana this week:

• Positive Sentiment: Humana’s improved 2027 Medicare Advantage Star Ratings reduced concerns about the company’s future bonus payments and plan profitability, prompting a sharp post-market rally. Humana surges post-market on boost in 2027 Medicare Advantage star ratings
• Positive Sentiment: Cantor Fitzgerald upgraded HUM from “Neutral” to “Overweight” and raised its price target to $460 from $300, reinforcing the bullish reaction to the ratings news. Humana stock rating raised to Overweight at Cantor Fitzgerald
• Positive Sentiment: The ratings outcome provides support for the recent investment thesis that Humana’s Medicare Advantage margins and operating performance could improve.
• Neutral Sentiment: Humana is scheduled to release its third-quarter 2026 interim results, giving investors another upcoming test of medical-cost trends and Medicare Advantage profitability. Humana sets date for third-quarter 2026 interim report
• Negative Sentiment: Before the CMS release, shares had pulled back as investors reduced exposure or took profits ahead of the ratings announcement. The move highlighted the stock’s sensitivity to Star Rating expectations, while the elevated valuation leaves room for volatility if future ratings or medical-cost results disappoint. Why Humana stock is falling today

About Humana

Humana Inc is a health and well-being company headquartered in Louisville, Kentucky. Founded in 1961, the company began as a nursing home operator before expanding into hospitals and health insurance. Today, Humana primarily provides health insurance products and healthcare services for older adults, individuals, military families and other members in the United States.

Humana’s insurance business offers Medicare Advantage, Medicare Supplement and prescription drug plans, as well as Medicaid coverage in select markets.